{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:44:34Z","timestamp":1772826274336,"version":"3.50.1"},"reference-count":83,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T00:00:00Z","timestamp":1431561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0126827","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T18:01:16Z","timestamp":1431626476000},"page":"e0126827","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Brucella spp. Lumazine Synthase Induces a TLR4-Mediated Protective Response against B16 Melanoma in Mice"],"prefix":"10.1371","volume":"10","author":[{"given":"Andr\u00e9s H.","family":"Rossi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Farias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier E.","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hern\u00e1n R.","family":"Bonomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando A.","family":"Goldbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula M.","family":"Berguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,5,14]]},"reference":[{"issue":"10","key":"ref1","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s00262-010-0833-1","article-title":"Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy","volume":"59","author":"G Schreibelt","year":"2010","journal-title":"Cancer immunology, immunotherapy: CII"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/35100529","article-title":"Toll-like receptors and innate immunity","volume":"1","author":"R Medzhitov","year":"2001","journal-title":"Nature reviews Immunology"},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1096\/fj.08-108274","article-title":"Engagement of Toll-like receptor-2 on cytotoxic T-lymphocytes occurs in vivo and augments antitumor activity","volume":"22","author":"N Asprodites","year":"2008","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2217\/imt.09.70","article-title":"Toll-like receptor agonists in cancer therapy","volume":"1","author":"S Adams","year":"2009","journal-title":"Immunotherapy"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1172\/JCI200419762","article-title":"Induction of potent antitumor immunity by in situ targeting of intratumoral DCs","volume":"113","author":"K Furumoto","year":"2004","journal-title":"The Journal of clinical investigation"},{"issue":"7335","key":"ref6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature09737","article-title":"Programming the magnitude and persistence of antibody responses with innate immunity","volume":"470","author":"SP Kasturi","year":"2011","journal-title":"Nature"},{"issue":"9","key":"ref7","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nm1622","article-title":"Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy","volume":"13","author":"L Apetoh","year":"2007","journal-title":"Nature medicine"},{"issue":"18","key":"ref8","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1158\/1078-0432.CCR-07-1378","article-title":"Toll-like receptors in tumor immunotherapy","volume":"13","author":"CM Paulos","year":"2007","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"ref9","first-page":"154","article-title":"The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas","volume":"26","author":"EF McCarthy","year":"2006","journal-title":"The Iowa orthopaedic journal"},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1517\/13543784.16.9.1391","article-title":"Early experience with novel immunomodulators for cancer treatment","volume":"16","author":"Z Thotathil","year":"2007","journal-title":"Expert opinion on investigational drugs"},{"issue":"18","key":"ref11","doi-asserted-by":"crossref","first-page":"7048","DOI":"10.1073\/pnas.0601554103","article-title":"Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells","volume":"103","author":"H Liu","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1172\/JCI25439","article-title":"Toll-like receptor 2 controls expansion and function of regulatory T cells","volume":"116","author":"RP Sutmuller","year":"2006","journal-title":"The Journal of clinical investigation"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.coi.2006.11.007","article-title":"Expression and function of Toll-like receptors in T lymphocytes","volume":"19","author":"D Kabelitz","year":"2007","journal-title":"Current opinion in immunology"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1158\/0008-5472.CAN-05-0784","article-title":"Toll-like receptors on tumor cells facilitate evasion of immune surveillance","volume":"65","author":"B Huang","year":"2005","journal-title":"Cancer research"},{"issue":"Suppl 1","key":"ref15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12307-009-0022-y","article-title":"Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment","volume":"2","author":"Y Sato","year":"2009","journal-title":"Cancer microenvironment: official journal of the International Cancer Microenvironment Society"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1186\/1471-2407-10-665","article-title":"Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis","volume":"10","author":"S Gonzalez-Reyes","year":"2010","journal-title":"BMC cancer"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00109-011-0807-6","article-title":"Involvement of TNFalpha-induced TLR4-NF-kappaB and TLR4-HIF-1alpha feed-forward loops in the regulation of inflammatory responses in glioma","volume":"90","author":"R Tewari","year":"2012","journal-title":"J Mol Med (Berl)"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/onc.2010.401","article-title":"Pancreatic adenocarcinoma upregulated factor promotes metastasis by regulating TLR\/CXCR4 activation","volume":"30","author":"HD Park","year":"2011","journal-title":"Oncogene"},{"issue":"32","key":"ref19","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.3748\/wjg.v17.i32.3745","article-title":"Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma","volume":"17","author":"I Sheyhidin","year":"2011","journal-title":"World journal of gastroenterology: WJG"},{"issue":"3","key":"ref20","first-page":"401","article-title":"The expression of SOCS1 and TLR4-NFkappaB pathway molecules in neoplastic cells as potential biomarker for the aggressive tumor phenotype in laryngeal carcinoma","volume":"47","author":"K Starska","year":"2009","journal-title":"Folia histochemica et cytobiologica \/ Polish Academy of Sciences, Polish Histochemical and Cytochemical Society"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/sj.bjc.6605558","article-title":"High expression of Toll-like receptor 4\/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer","volume":"102","author":"EL Wang","year":"2010","journal-title":"British journal of cancer"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1245\/s10434-009-0325-8","article-title":"Silencing of TLR4 decreases liver tumor burden in a murine model of colorectal metastasis and hepatic steatosis","volume":"16","author":"TM Earl","year":"2009","journal-title":"Annals of surgical oncology"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00403-012-1300-y","article-title":"Expression of TLR3, 4, 7 and 9 in cutaneous malignant melanoma: relationship with clinicopathological characteristics and prognosis","volume":"305","author":"N Eiro","year":"2013","journal-title":"Archives of dermatological research"},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.leu.2404226","article-title":"Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors","volume":"20","author":"G Jego","year":"2006","journal-title":"Leukemia"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3892\/etm.2011.400","article-title":"Monthly intravesical bacillus Calmette-Guerin maintenance therapy for non-muscle-invasive bladder cancer: 10-year experience in a single institute","volume":"3","author":"KH Yoo","year":"2012","journal-title":"Experimental and therapeutic medicine"},{"issue":"12","key":"ref26","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.1128\/IAI.68.12.6883-6890.2000","article-title":"Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guerin: involvement of toll-like receptors","volume":"68","author":"S Tsuji","year":"2000","journal-title":"Infection and immunity"},{"issue":"11","key":"ref27","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1172\/JCI35890","article-title":"CD4+CD25+ Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancer","volume":"118","author":"S Roux","year":"2008","journal-title":"The Journal of clinical investigation"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"R8","DOI":"10.1186\/gb-2007-8-1-r8","article-title":"Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection","volume":"8","author":"MC Panelli","year":"2007","journal-title":"Genome biology"},{"issue":"15","key":"ref29","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/jnci\/dji207","article-title":"Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment","volume":"97","author":"M Urosevic","year":"2005","journal-title":"Journal of the National Cancer Institute"},{"issue":"3","key":"ref30","first-page":"241","article-title":"Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience","volume":"79","author":"DK Tillman Jr.","year":"2007","journal-title":"Cutis"},{"issue":"5","key":"ref31","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1006\/jmbi.2000.3640","article-title":"Divergence in macromolecular assembly: X-ray crystallographic structure analysis of lumazine synthase from Brucella abortus","volume":"297","author":"BC Braden","year":"2000","journal-title":"Journal of molecular biology"},{"issue":"9","key":"ref32","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.1074\/jbc.M312035200","article-title":"High order quaternary arrangement confers increased structural stability to Brucella sp. lumazine synthase","volume":"279","author":"V Zylberman","year":"2004","journal-title":"The Journal of biological chemistry"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/prot.20248","article-title":"Engineering of a polymeric bacterial protein as a scaffold for the multiple display of peptides","volume":"57","author":"DA Laplagne","year":"2004","journal-title":"Proteins"},{"issue":"21","key":"ref34","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1016\/j.vaccine.2004.11.043","article-title":"Brucella spp. lumazine synthase: a novel antigen delivery system","volume":"23","author":"E Sciutto","year":"2005","journal-title":"Vaccine"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/prot.20635","article-title":"Multiple display of a protein domain on a bacterial polymeric scaffold","volume":"61","author":"PO Craig","year":"2005","journal-title":"Proteins"},{"issue":"5","key":"ref36","first-page":"1277","article-title":"Brucella spp. lumazine synthase: a novel adjuvant and antigen delivery system to effectively induce oral immunity. Microbes and infection \/","volume":"8","author":"G Rosas","year":"2006","journal-title":"Institut Pasteur"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.4049\/jimmunol.176.4.2366","article-title":"A polymeric bacterial protein activates dendritic cells via TLR4","volume":"176","author":"PM Berguer","year":"2006","journal-title":"J Immunol"},{"issue":"9","key":"ref38","doi-asserted-by":"crossref","first-page":"e45705","DOI":"10.1371\/journal.pone.0045705","article-title":"A polymeric protein induces specific cytotoxicity in a TLR4 dependent manner in the absence of adjuvants","volume":"7","author":"PM Berguer","year":"2012","journal-title":"PloS one"},{"issue":"10","key":"ref39","first-page":"3608","article-title":"Tumoricidal properties of mouse macrophages activated with mediators from rat lymphocytes stimulated with concanavalin A","volume":"36","author":"IJ Fidler","year":"1976","journal-title":"Cancer research"},{"issue":"5","key":"ref40","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/jnci\/57.5.1199","article-title":"Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines","volume":"57","author":"IJ Fidler","year":"1976","journal-title":"Journal of the National Cancer Institute"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.4049\/jimmunol.165.5.2651","article-title":"Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma","volume":"165","author":"M Bellone","year":"2000","journal-title":"J Immunol"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/archderm.135.3.275","article-title":"Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry","volume":"135","author":"LK Dennis","year":"1999","journal-title":"Archives of dermatology"},{"issue":"16","key":"ref43","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","article-title":"Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system","volume":"19","author":"CM Balch","year":"2001","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"3","key":"ref44","first-page":"131","article-title":"An evidence-based staging system for cutaneous melanoma","volume":"54","author":"CM Balch","year":"2004","journal-title":"CA: a cancer journal for clinicians"},{"issue":"11","key":"ref45","first-page":"1403","article-title":"Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma","volume":"68","author":"SA Del Prete","year":"1984","journal-title":"Cancer treatment reports"},{"issue":"9","key":"ref46","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1200\/JCO.1999.17.9.2745","article-title":"Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma","volume":"17","author":"PB Chapman","year":"1999","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1200\/JCO.2000.18.1.158","article-title":"Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma","volume":"18","author":"MR Middleton","year":"2000","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"6","key":"ref48","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1053\/j.seminoncol.2007.09.008","article-title":"Management of metastatic melanoma","volume":"34","author":"HA Tawbi","year":"2007","journal-title":"Seminars in oncology"},{"issue":"1","key":"ref49","first-page":"S39","article-title":"Durable complete responses in metastatic melanoma treated with interleukin-2 in combination with interferon alpha and chemotherapy","volume":"24","author":"SS Legha","year":"1997","journal-title":"Seminars in oncology"},{"issue":"3","key":"ref50","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0360-3016(99)00066-8","article-title":"Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience","volume":"44","author":"MH Seegenschmiedt","year":"1999","journal-title":"International journal of radiation oncology, biology, physics"},{"issue":"11","key":"ref51","first-page":"1149","article-title":"Systemic treatments for advanced cutaneous melanoma","volume":"9","author":"CM Anderson","year":"1995","journal-title":"Oncology (Williston Park)"},{"key":"ref52","article-title":"Clinical deployment of antibodies for treatment of melanoma","author":"BD Curti","year":"2015","journal-title":"Molecular immunology"},{"issue":"2","key":"ref53","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11864-014-0283-7","article-title":"Update on vaccines for high-risk melanoma","volume":"15","author":"SA Weiss","year":"2014","journal-title":"Current treatment options in oncology"},{"issue":"9","key":"ref54","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1002011","article-title":"Inhibition of mutated, activated BRAF in metastatic melanoma","volume":"363","author":"KT Flaherty","year":"2010","journal-title":"The New England journal of medicine"},{"issue":"3","key":"ref55","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/sj.bjc.6606030","article-title":"Targeting BRAF for patients with melanoma","volume":"104","author":"HT Arkenau","year":"2011","journal-title":"British journal of cancer"},{"issue":"12","key":"ref56","doi-asserted-by":"crossref","first-page":"e28973","DOI":"10.1371\/journal.pone.0028973","article-title":"Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT\/mTOR pathway","volume":"6","author":"M Atefi","year":"2011","journal-title":"PloS one"},{"issue":"5B","key":"ref57","first-page":"3709","article-title":"Inhibition of melanogenesis as an adjuvant strategy in the treatment of melanotic melanomas: selective review and hypothesis","volume":"18","author":"A Slominski","year":"1998","journal-title":"Anticancer research"},{"issue":"4","key":"ref58","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1152\/physrev.00044.2003","article-title":"Melanin pigmentation in mammalian skin and its hormonal regulation","volume":"84","author":"A Slominski","year":"2004","journal-title":"Physiological reviews"},{"issue":"1","key":"ref59","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1755-148X.2011.00898.x","article-title":"L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions","volume":"25","author":"A Slominski","year":"2012","journal-title":"Pigment cell & melanoma research"},{"issue":"10","key":"ref60","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.humpath.2013.02.022","article-title":"Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma","volume":"44","author":"AA Brozyna","year":"2013","journal-title":"Human pathology"},{"issue":"3","key":"ref61","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.immuni.2008.08.004","article-title":"Cancer immunotherapy by dendritic cells","volume":"29","author":"CJ Melief","year":"2008","journal-title":"Immunity"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1749-6632.2009.05000.x","article-title":"Harnessing dendritic cells to generate cancer vaccines","volume":"1174","author":"K Palucka","year":"2009","journal-title":"Annals of the New York Academy of Sciences"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1479-5876-6-6","article-title":"A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic\/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10\u20131082 promoter genotype as predictor of disease progression","volume":"6","author":"EM von Euw","year":"2008","journal-title":"Journal of translational medicine"},{"issue":"51","key":"ref64","doi-asserted-by":"crossref","first-page":"8162","DOI":"10.1016\/j.vaccine.2010.09.095","article-title":"Vaccination with dendritic cells charged with apoptotic\/necrotic B16 melanoma induces the formation of subcutaneous lymphoid tissue","volume":"28","author":"S Mac Keon","year":"2010","journal-title":"Vaccine"},{"issue":"11","key":"ref65","doi-asserted-by":"crossref","first-page":"5940","DOI":"10.4049\/jimmunol.171.11.5940","article-title":"Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma","volume":"171","author":"RS Goldszmid","year":"2003","journal-title":"J Immunol"},{"issue":"9","key":"ref66","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1099\/00222615-48-9-833","article-title":"The 18-kDa cytoplasmic protein of Brucella species\u2014an antigen useful for diagnosis\u2014is a lumazine synthase","volume":"48","author":"FA Goldbaum","year":"1999","journal-title":"Journal of medical microbiology"},{"issue":"21","key":"ref67","doi-asserted-by":"crossref","first-page":"10519","DOI":"10.1158\/0008-5472.CAN-07-0079","article-title":"Activation of Toll-like receptor 4 on tumor cells in vitro inhibits subsequent tumor growth in vivo","volume":"67","author":"V Andreani","year":"2007","journal-title":"Cancer research"},{"issue":"8","key":"ref68","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.4049\/jimmunol.176.8.4894","article-title":"TLR3 can directly trigger apoptosis in human cancer cells","volume":"176","author":"B Salaun","year":"2006","journal-title":"J Immunol"},{"issue":"10","key":"ref69","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.intimp.2007.05.016","article-title":"Toll-like receptors in inflammation, infection and cancer","volume":"7","author":"K Chen","year":"2007","journal-title":"International immunopharmacology"},{"issue":"5","key":"ref70","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1172\/JCI31414","article-title":"Development of TLR9 agonists for cancer therapy","volume":"117","author":"AM Krieg","year":"2007","journal-title":"The Journal of clinical investigation"},{"issue":"1","key":"ref71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20090272","article-title":"Pathogen recognition in the innate immune response","volume":"420","author":"H Kumar","year":"2009","journal-title":"The Biochemical journal"},{"issue":"1","key":"ref72","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.semcancer.2005.07.004","article-title":"Toll-like receptors, inflammation and cancer","volume":"16","author":"MF Tsan","year":"2006","journal-title":"Seminars in cancer biology"},{"issue":"5","key":"ref73","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nm1589","article-title":"Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists","volume":"13","author":"H Kanzler","year":"2007","journal-title":"Nature medicine"},{"issue":"2","key":"ref74","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/sj.onc.1210904","article-title":"TLR signaling by tumor and immune cells: a double-edged sword","volume":"27","author":"B Huang","year":"2008","journal-title":"Oncogene"},{"issue":"1","key":"ref75","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10555-011-9279-y","article-title":"Tumor microenvironment is multifaceted","volume":"30","author":"C Sautes-Fridman","year":"2011","journal-title":"Cancer metastasis reviews"},{"issue":"8","key":"ref76","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"FS Hodi","year":"2010","journal-title":"The New England journal of medicine"},{"issue":"3","key":"ref77","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00403-012-1223-7","article-title":"Upcoming strategies for the treatment of metastatic melanoma","volume":"304","author":"F Spagnolo","year":"2012","journal-title":"Archives of dermatological research"},{"issue":"9","key":"ref78","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1084\/jem.20130573","article-title":"Activating Fc gamma receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies","volume":"210","author":"Y Bulliard","year":"2013","journal-title":"The Journal of experimental medicine"},{"issue":"1","key":"ref79","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1158\/2326-6066.CIR-13-0013","article-title":"Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells","volume":"1","author":"MJ Selby","year":"2013","journal-title":"Cancer immunology research"},{"issue":"9","key":"ref80","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1084\/jem.20130579","article-title":"Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma","volume":"210","author":"TR Simpson","year":"2013","journal-title":"The Journal of experimental medicine"},{"issue":"3","key":"ref81","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1158\/0008-5472.CAN-11-0534","article-title":"IFNbeta produced by TLR4-activated tumor cells is involved in improving the antitumoral immune response","volume":"72","author":"NG Nunez","year":"2012","journal-title":"Cancer research"},{"issue":"6","key":"ref82","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/ijc.23664","article-title":"Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy","volume":"123","author":"AA Brozyna","year":"2008","journal-title":"International journal of cancer Journal international du cancer"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.abb.2014.06.030","article-title":"The role of melanogenesis in regulation of melanoma behavior: melanogenesis leads to stimulation of HIF-1alpha expression and HIF-dependent attendant pathways","volume":"563","author":"A Slominski","year":"2014","journal-title":"Archives of biochemistry and biophysics"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0126827","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T03:14:32Z","timestamp":1566702872000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0126827"}},"subtitle":[],"editor":[{"given":"Andrzej T","family":"Slominski","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,14]]},"references-count":83,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0126827","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,14]]}}}